George Landon Beales, MD | |
2146 Pheasant Lane, Holladay, UT 84121-1356 | |
(801) 278-4965 | |
Not Available |
Full Name | George Landon Beales |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 2146 Pheasant Lane, Holladay, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558570770 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 1462191205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
George Landon Beales, MD 2146 Pheasant Lane, Holladay, UT 84121-1356 Ph: (801) 278-4965 | George Landon Beales, MD 2146 Pheasant Lane, Holladay, UT 84121-1356 Ph: (801) 278-4965 |
News Archive
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
A Medicare program that has agreed to pay for counseling for seniors who smoke but are not yet sick could help the program, and America's health system, lower costs.
Hodgkin's lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don't have the screening and the intervention is cost-effective, according to a study presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Ipsen announced today that its partner Inspiration Biopharmaceuticals, Inc. has initiated treatment of patients in the first of two phase III pivotal clinical studies of OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, for the treatment of acquired hemophilia A, a rare, though potentially life-threatening bleeding disorder.
› Verified 4 days ago
Stephen B Smith, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1624 E 4500 S, Holladay, UT 84117 Phone: 801-266-7200 Fax: 801-266-7004 | |
Dr. Sheetal Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4252 S Highland Dr Ste 200, Holladay, UT 84124 Phone: 801-965-3600 |